Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 1, 2007

GenomeQuest and Servier Develop Software that Integrates Biological Data Sets

  • GenomeQuest and Servier have produced a system that optimizes experimental study design and analysis by providing a simple way to view and examine the exhaustive set of transcripts and biological assays for a gene.

    The results are part of a collaboration to connect results from high-throughput microarray experiments to qPCR platforms from different vendors, including Servier’s reagent data sets. Servier provided scientific insights to form product requirements, while GenomeQuest leveraged its bioinformatics, high-performance computing, and data management expertise.

    Through this partnership, Servier receives highly maintainable gene catalogs for human, mouse, and rat and a companion visualization module that integrates all of its content with public and vendor reagent libraries. In turn, GenomeQuest retained the right to commercialize the software and know-how to help other companies with a similar requirement to integrate their own data sets.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »